AVITA Medical, Inc (RCEL)

Etorro trading 970x250
AVITA Medical, Inc (RCEL) Logo

About AVITA Medical, Inc

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company’s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient’s own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California. Address: 28159 Avenue Stanford, Valencia, CA, United States, 91355

AVITA Medical, Inc News and around…

Latest news about AVITA Medical, Inc (RCEL) common stock and company :

AVITA Medical: Q3 Earnings Insights
12 May, 2022 FinancialContent

AVITA Medical (NASDAQ:RCEL) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know ...

AVITA Medical Reports First Quarter 2022 Financial Results
12 May, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, May 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its first quarter ended March 31, 2022. Financial Highlights and Recent Updates: Reported commercial revenue, which excludes BARDA revenue, of $7.4 mil

Earnings Scheduled For May 12, 2022
12 May, 2022 FinancialContent

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its ...

RECELL® System to be Highlighted at Upcoming Music City SCALE Multidisciplinary Dermatology Meeting
09 May, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that a discussion on the RECELL System will be held during the Symposium for Cosmetic Advances & Laser Education (SCALE) multidisciplinary dermatology meeting taking place May 11

AVITA Medical to Announce First Quarter 2022 Financial Results
28 Apr, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, April 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that it will release its first quarter 2022 financial results on Thursday, May 12, 2022. In conjunction with such release, the Company plans to host a conference call and webcast that da

Stocks That Hit 52-Week Lows On Tuesday
26 Apr, 2022 FinancialContent

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms ...

Avita Medical, Inc. Announces Resignation of Louis Drapeau from Board of Directors
21 Apr, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, April 21, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that Louis Drapeau has resigned, effective April 29, 2022, from the Company’s Board of Directors. Mr. Drapeau’s resignation is not because of a disagreement with the Company on

RECELL® System Data to be Presented at the American Burn Association Annual Meeting
04 Apr, 2022 Yahoo! Finance

Data from 15 presentations will highlight the use of the platform for the treatment of pediatric and adult burn woundsVALENCIA, Calif. and MELBOURNE, Australia, April 04, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that fifteen presentations highlighting the clinical and cost-saving

Notable Tuesday Option Activity: RCEL, AMC, BYND
29 Mar, 2022 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in AVITA Medical Inc (RCEL), where a total of 4,875 contracts have traded so far, representing approximately 487,500 underlying shares. That amounts to about 227.3% of RCEL's average daily trading volume over the past month of 214,460 shares..

RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
23 Mar, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, March 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that an abstract highlighting the clinical trial protocol utilizing the RECELL® Autologous Cell Harvesting Device (RECELL® System) to treat vitiligo will be presented at the Global Vitil

AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction
22 Mar, 2022 FinancialContent

Biomedical Advanced Research and Development Authority (BARDA) hasmodified its contractwithAVITA Medical ...

AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction
21 Mar, 2022 Yahoo! Finance

Funds will support completion of the ongoing pivotal clinical trialVALENCIA, Calif. and MELBOURNE, Australia, March 21, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that the Biomedical Advanced Research and Development Authority (BARDA) has modified its existing contract with the Com

AVITA Medical Inks Supply Pact With Premier For RECELL System
03 Mar, 2022 FinancialContent

AVITA Medical Inc(NASDAQ: RCEL) has beenawarded a group purchasing agreementwithPremier Inc(NASDAQ: ...

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
03 Mar, 2022 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary ...

Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems Across the U.S.
02 Mar, 2022 Yahoo! Finance

Agreement ensures timely access to the RECELL System for the approximately 4,440 U.S. hospitals and health systems in Premier’s networkVALENCIA, Calif. and MELBOURNE, Australia, March 02, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that they have been awarded a group purchasing agre

80 Biggest Movers From Yesterday
02 Mar, 2022 FinancialContent

Gainers Avenue Therapeutics, Inc.(NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on ...

44 Stocks Moving In Tuesday's Mid-Day Session
01 Mar, 2022 FinancialContent

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) ...

AVITA Medical: Q2 Earnings Insights
28 Feb, 2022 FinancialContent

AVITA Medical (NASDAQ:RCEL) reported its Q2 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need ...

AVITA Medical Reports Quarter Ending December 31, 2021, and Transition Period July 1, 2021, to December 31, 2021, Financial Results
28 Feb, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (the “Company”), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported its financial results for the quarter ending December 31, 2021, and its transition period fiscal year ("Transition Period") from July 1, 2021, to December 31, 2021. As annou

Earnings Scheduled For February 28, 2022
28 Feb, 2022 FinancialContent

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its ...

The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC, an M3 Group Company
23 Feb, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market the RECELL® System in Japan. COSMOTEC, an M3 Group Company, championed the approval

AVITA Medical to Present at the Cowen 42nd Annual Health Care Conference
23 Feb, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that Dr. Mike Perry, CEO, will present at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 12:50 p.m. Eastern Standard Time (Wednesday, March 9, 2022 at 4:50 a.m.

Futures Flat As Traders Brace For Op-Ex Volatility, More Ukraine Headlines
18 Feb, 2022 FinancialContent

In the latest geopolitical developments Russian Foreign Minister Sergei Lavrov agreed to meet US Secretary of State Antony Blinken for talks in Europe next week; German Chancellor Olaf Scholz will host virtual talks with his Group of 7 counterparts.

12 Health Care Stocks Moving In Thursday's After-Market Session
17 Feb, 2022 FinancialContent

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 14.6% to $1.8 during Thursday's after-market session. At the close, ...

AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use
17 Feb, 2022 Yahoo! Finance

System enhanced in response to clinician workflow and usability feedback; new system simplifies process United States product launch planned for Q2 2022 VALENCIA, Calif. and MELBOURNE, Australia, Feb. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that the United States Food and Dr

AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial Results
15 Feb, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that it plans to release its July 1, 2021 to December 31, 2021 financial results after the market closes on Monday, February 28, 2022. In conjunction with such release, the Company plans

RSI Alert: AVITA Medical (RCEL) Now Oversold
14 Feb, 2022 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

AVITA Medical to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
02 Feb, 2022 Yahoo! Finance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that Dr. Mike Perry, CEO, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022 at 10:30 a.m. Eastern Standard Time (W

RECELL® System Data to be Presented at 44th Annual John A. Boswick Burn & Wound Care Symposium
24 Jan, 2022 Yahoo! Finance

Data presentations highlight broad clinical adoption of the RECELL® System for treatment of burn woundsVALENCIA, Calif. and MELBOURNE, Australia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that six abstracts highlighting the clinical benefits of the RECELL® Autologous Cell

52 Weeks High And Low Article
11 Jan, 2022 FinancialContent

Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy ...

AVITA Medical, Inc (RCEL) is a NASDAQ Common Stock listed in , ,

970x250